Ozempic quells kidney disease risk, study finds

6 months ago 41

In a yearslong trial of more than 3,500 participants, Novo Nordisk's Ozempic and Wegovy slowed the growth of chronic kidney disease and slashed the risk of heart attack, kidney failure, stroke and death.

View Entire Post

Read Entire Article

Ozempic quells kidney disease risk, study finds

In a yearslong trial of more than 3,500 participants, Novo Nordisk's Ozempic and Wegovy slowed the growth of chronic kidney disease and slashed the risk of heart attack, kidney failure, stroke and death.

Related

Jeremy Renner's Recovery Home From Snowplow Accident Finds Another Celebrity Owner

Regulation of disease-associated microglia in the optic nerve by lipoxin B4 and ocular hypertension

These are the Perfect Suede Trucker Jackets at Every Price: From Affordable Finds to Investment-Worthy Classics (+5 Outfit Ideas)

Leapfrog Group Finds Significant Improvements in Patient Safety

Study: Rising diabetes in Malaysia; food costs, social pressure hinder healthy choices

Victor Marx Takes High-Risk Mission to Haiti to Protect Vulnerable Communities Amid Gang Violence

More News From Beckers Hospital Review

Judge dismisses lawsuit over New York system CEO's firing: 8 notes

Late-career physician assessments have room to improve: Study

Dartmouth to pull maternity services from Catholic Medical Center

UK HealthCare's new network for partnerships, training: 6 things to know

UMass hospital cuts heart failure readmissions in half

Hospitals prepare for months-long supply disruptions after Helene, port strike

Trending

Popular

What is Authentic Project Based Learning (PBL)?

Wall Street hits record high after Trump election win, as US dollar, bitcoin and Tesla shares surge – as it happened

Marathe departs ALM for The Insurer, a Reuters publication

A single grant of $123M has been finalized from $33B+ announced so far under the US CHIPS Act, which is facing criticism on both sides of the political aisle (Politico)

The NYC Marathon Is the Best Pick-Me-Up

Mainstream Media Was Afraid to Compare Trump to Hitler. Now the Press Has No Excuse.

Ozempic quells kidney disease risk, study finds

In a yearslong trial of more than 3,500 participants, Novo Nordisk's Ozempic and Wegovy slowed the growth of chronic kidney disease and slashed the risk of heart attack, kidney failure, stroke and death.

Related

Jeremy Renner's Recovery Home From Snowplow Accident Finds Another Celebrity Owner

Regulation of disease-associated microglia in the optic nerve by lipoxin B4 and ocular hypertension

These are the Perfect Suede Trucker Jackets at Every Price: From Affordable Finds to Investment-Worthy Classics (+5 Outfit Ideas)

Leapfrog Group Finds Significant Improvements in Patient Safety

Study: Rising diabetes in Malaysia; food costs, social pressure hinder healthy choices

Victor Marx Takes High-Risk Mission to Haiti to Protect Vulnerable Communities Amid Gang Violence

More News From Beckers Hospital Review

Judge dismisses lawsuit over New York system CEO&#039;s firing: 8 notes

Late-career physician assessments have room to improve: Study

Dartmouth to pull maternity services from Catholic Medical Center

UK HealthCare&#039;s new network for partnerships, training: 6 things to know

UMass hospital cuts heart failure readmissions in half

Hospitals prepare for months-long supply disruptions after Helene, port strike

Trending

Popular

What is Authentic Project Based Learning (PBL)?

Wall Street hits record high after Trump election win, as US dollar, bitcoin and Tesla shares surge – as it happened

Marathe departs ALM for The Insurer, a Reuters publication

A single grant of $123M has been finalized from $33B+ announced so far under the US CHIPS Act, which is facing criticism on both sides of the political aisle (Politico)

The NYC Marathon Is the Best Pick-Me-Up

Mainstream Media Was Afraid to Compare Trump to Hitler. Now the Press Has No Excuse.

Judge dismisses lawsuit over New York system CEO's firing: 8 notes

UK HealthCare's new network for partnerships, training: 6 things to know